The National Organization for Rare Disorders is starting a patient-driven campaign to highlight the significant impact that the Affordable Care Act has had on patients with rare and chronic diseases. Some noticeable changes for these patients was prohibiting discrimination against patients with pre-existing conditions, as well as the eliminating the lifetime and annual caps on coverage. If the ACA is repealed without a comparable substitute put in its place, rare and chronic patients risk losing coverage and benefits that are crucial to their health and long-term care. By sharing your story, you can join the campaign and help ensure patients voices are heard!
Share Your Story, Protect Your Healthcare Coverage
The National Organization for Rare Disorders is starting a patient-driven campaign to highlight the significant impact that the Affordable Care Act has had on patients with rare and chronic diseases. Some noticeable changes for these patients was prohibiting discrimination against patients with pre-existing conditions, as well as the eliminating the lifetime and annual caps onLearn More
February 9, 2017
Categories
Recent Posts
- FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs
- FSR receives confirmation from the Department of Labor ensuring patient access to FMLA for participation in clinical trials
- Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
- 12 Years of Sarcoidosis Advocacy
- Sarcoidosis…and the Sound of Silence